{
    "eid": "2-s2.0-85077298558",
    "title": "Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: Secondary analysis from a prospective randomized trial",
    "cover-date": "2019-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Nasopharyngeal cancer",
        "Plasma EBV DNA",
        "TNM staging"
    ],
    "authors": [
        "Sarin Kitpanit",
        "Nutchawan Jittapiromsak",
        "Aniwat Sriyook",
        "Anussara Prayongrat",
        "Danita Kannarunimit",
        "Chakkapong Chakkabat",
        "Chawalit Lertbutsayanukul"
    ],
    "citedby-count": 7,
    "ref-count": 33,
    "ref-list": [
        "A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma",
        "Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system",
        "Recommendations for updating T and N staging systems for nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy",
        "Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy",
        "The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more 'personalized' approach to cancer staging",
        "Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi",
        "Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy",
        "Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era",
        "Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: Analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers",
        "Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma",
        "The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification",
        "Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: Patterns of spread",
        "Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: Prognostic value and staging categories",
        "The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging",
        "Magnetic resonance imaging staging of nasopharyn-geal carcinoma in the head and neck",
        "Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence",
        "A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; Preliminary result on acute adverse events",
        "A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma",
        "Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy",
        "Circulating EBV DNA, globulin and nodal size predict distant metastasis after intensity-modulated radiotherapy in stage II nasopharyngeal carcinoma",
        "Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma",
        "Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy",
        "Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): A multicentre cohort study",
        "Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis",
        "Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma",
        "Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopha-ryngeal cancer in a non-endemic area",
        "Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undiffer-entiated type",
        "Plasma Epstein-Barr viral deoxyribo-nucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma",
        "Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy",
        "Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma",
        "Prognostic nomogram for patients with naso-pharyngeal carcinoma incorporating hematological biomarkers and clinical characteristics",
        "Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}